Nalaganje...
Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
Since their initial availability in 1997, the thiazolidinediones (TZDs) have become one of the most commonly prescribed classes of medications for type 2 diabetes. In addition to glucose control, the TZDs have a number of pleiotropic effects on myriad traditional and non-traditional risk factors for...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2496982/ https://ncbi.nlm.nih.gov/pubmed/18561505 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|